Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs


TOKYO, Sept. 27, 2023 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately 907 million yen (US$6.2 million1) for the development of a new prophylactic vaccine against malaria and a new anti-malarial drug and approximately 273…

Leave a Reply